PolyNovo Limited

PolyNovo Limited is a medical technology company specializing in the development, manufacture, and sale of innovative biodegradable medical devices. The company is known for leveraging its patented NovoSorb® bioabsorbable polymer platform to create synthetic products that facilitate tissue repair and regeneration. PolyNovo’s flagship product, NovoSorb Biodegradable Temporizing Matrix (BTM), functions as a dermal scaffold aiding the reconstruction and healing of skin and soft tissue following extensive surgery, trauma, or burns. This technology supports the regeneration of the dermal layer and gradually degrades into harmless by-products fully absorbed by the body, offering a unique solution for complex wound management. Beyond BTM, PolyNovo is actively expanding its portfolio to include devices for hernia repair and reconstructive surgery, as well as research into innovative applications such as an intracutaneous ectopic pancreas for type 1 diabetes. With significant operations and sales in regions including Australia, the United States, the United Kingdom, and parts of Asia, PolyNovo plays a prominent role in advancing medical device innovation within the healthcare sector. The company’s focus on biocompatibility and clinical outcomes positions it as a noteworthy contributor to medical device solutions for challenging clinical scenarios.